Myocardial dysfunction in sepsis

Sepsis

Volumn 4, Issue 2, 2001, Pages 89-97

  Dhainaut, J F ^a   Cariou, A ^a   Laurent, I ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INTERLEUKIN 1; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HUMAN; HUMAN CELL; INCIDENCE; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEPSIS;

EID: 0035013666     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011446602717     Document Type: Review

References (72)

1. The septic syndrome. Definition and clinical implications
2. Therapeutic perspectives in sepsis
3. Mechanisms of decreased cardiac function in sepsis
4. Myocardial dysfunction in sepsis: Mechanisms and therapeutic implications
5. Cardiovascular performance with E. coli challenges in a canine model of human sepsis
6. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock
7. Myocardial energy metabolism and morphology in a canine model of sepsis
8. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits
9. Sepsis-induced diastolic dysfunction in chronic canine peritonitis
10. Cardiac dysfunction in a rat model of chronic bacteremia
11. Alteration of beta-adrenergic pathway in the septic heart
12. Volume expansion, dobutamine and noradrenaline for treatment or right ventricular dysfunction in porcine septic shock: A combined invasive and radionuclide study
13. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock
14. The cardiovascular response of normal humans to the administration of endotoxin
15. Profound but reversible myocardial depression in patients with septic shock
16. Sepsis-related cardiogenic shock
17. Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock
18. Hemodynamic determinants of mortality in human septic shock
19. The effects of coronary artery disease on cardiac dysfunction in non hypotensive sepsis
20. Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study
21. Right ventricular dysfunction in human septic shock
22. Right ventricular dysfunction in septic shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique
23. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
24. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
25. Cardiac myocytes release leukocyte-stimulating factors
26. Prolonged leukocyte transit time in coronary circulation of endotoxemic pigs
27. Myocardial oxygen extraction ratio is decreased during endotoxemia in pigs
28. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs
29. A circulating myocardial depressant substance in humans with septic shock
30. Hemofiltration and left ventricular function in sepsis: Mechanisms and clinical implications
31. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock
32. Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in vitro myocardial cell contractility induced by serum from humans with septic shock
33. Endotoxemia in human septic shock
34. Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection
35. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: Impairment of signal transduction
36. 2+ transients and adenylate cyclase activity
37. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
38. 2+ transients
39. I and contractility in isolated adult rabbit ventricular myocytes
40. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the shingolipid signaling cascade cell death
41. Anti-tumor necrosis factor-α prevents decreased ventricular contractility in endotoxemic pigs
42. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia
43. Administration of anti-TNF antibody improves left ventricular function in septic shock patients
44. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle
45. The endocardial endothelium
46. Abnormal contraction function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
47. Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts
48. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
49. Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells
50. Cyclic AMP phosphodiesterases and calcium current regulation in cardiac cells
51. New insights into the regulation of inducible nitric oxide synthesis
52. Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat
53. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock
54. Plasma thromboxane concentrations are raised in patients dying with septic shock
55. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture
56. Coronary circulation in sepsis
57. The effect of hyperdynamic sepsis on myocardial performance
58. Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock
59. Interaction of sepsis and sepsis plus sympathomimetics on myocardial oxygen availability
60. High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats
61. Myocardial metabolism and coronary flow: Effects of endotoxemia
62. The coronary circulation in human septic shock
63. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in human septic shock
64. Sepsis depresses the metabolic oxygen reserve of the coronary circulation in mature sheep
65. Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits
66. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction
67. Protective effects of N-acetylcysteine in endotoxemia
68. Coronary vasoconstriction by endothelin-1 in anesthetized goats: Role of endothelin receptors, nitric oxide and prostanoids
69. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats
70. The coronary circulation and the myocardial oxygen supply/uptake relationship
71. Myocardial cell injury in septic shock
72. Cardiacspecific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes